Nausea, vomiting, or food aversion in the early weeks can limit intake further, which is part of why it treats this as worth raising early
Approval is expected in 2027, pending successful completion of Phase 3 trials
Patients should be aware that ongoing treatment is typically required to preserve the benefits. Nausea and Tolerance One of the common side effects when starting GLP-1 receptor agonists is nausea
Sedating antihistamines, certain blood pressure medications, anticholinergic drugs, and others may contribute to mental cloudiness
and patients who are critically ill [14][21]
(Someone with lower appetite or lower activity levels may fall closer to the lower end of that range.) Protein needs may be higher for people who: strength train regularly are postmenopausal are trying to preserve muscle during rapid weight loss have a higher starting body weight are physically active At the same time, its important to be realistic